运动干预对帕金森病患者执行功能的影响:主要和调节效应的元分析
Cheng-Liang Chang1, Sz-Yan Wu2, Daphne I Ling3
1Institute of Physical Education, Health and Leisure Studies, National Cheng Kung University, Taiwan.
Biological psychology
|June 7, 2025
概括
运动在帕金森病 (PD) 中显著改善执行功能 (EF),特别是认知灵活性. 最佳的计划包括心身炼,中等到强烈的强度,每周两次45-60分钟的会议.
科学领域:
- 神经科学是一个神经科学.
- 运动生理学 运动生理学
- 康复科学 康复科学 康复科学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,影响运动和非运动功能,包括执行功能 (EF).
- 在PD中增强EF的最佳运动处方仍然不清楚,报告结果的变化.
- 个别的PD特征可能会影响EF改善的运动有效性.
研究的目的:
- 系统地审查和元分析运动对PD患者EF的影响.
- 为了确定EF增强的最佳运动处方变量 (频率,强度,类型,持续时间).
- 调查PD特征对运动诱导的EF改善的缓和影响.
主要方法:
- 临床试验的系统审查和元分析.
- 搜索了六个电子数据库 (Embase,PubMed,MEDLINE,学术搜索完整,CINAHL,AGELINE) 至2024年4月.
- 包括18项符合PD患者慢性运动干预资格标准的研究.
主要成果:
- 运动显示了对EF的小但显著的整体积极影响 (ES=0.21,p < .001).
- 认知灵活性在EF子域中显示出最显著的改善.
- 更高的频率 (≥2/周),中等至强烈的强度,心身炼和45-60分钟的会议产生了更大的效果大小.
- 年龄较大,较高的勒沃多巴每日相当剂量 (LEDD ≥600 mg/day) 和基线认知障碍减弱了运动的益处.
结论:
- 运动是一种有前途的非药物策略,可以改善PD的EF,特别是认知灵活性.
- 建议进行心身炼,强度中等至强烈,每周两次进行45-60分钟的炼.
- 在老年人,高LEDD和认知障碍者中,运动的益处减少;建议早期参与.
相关概念视频
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723


